Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Hair loss in women can improve with iron and vitamin supplements if caused by iron deficiency.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

The patient's hair loss is most likely due to diffuse alopecia areata.

Patient history is key in diagnosing hair loss types.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Transplanted hair follicles can resist hair loss from an autoimmune condition better than natural hair.

A rare case showed hair regrowth after chemotherapy for thymoma, suggesting a link between alopecia areata and thymoma.

The conclusion is that it's important to tell apart alopecia areata from lipedematous alopecia for proper treatment, as alopecia areata can be reversed.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

A man had an unusual type of hair loss that didn't match known patterns and didn't improve with treatment.

An 82-year-old woman's hair turned white suddenly, likely due to a rare form of alopecia that targets pigmented hair.

More atypical club hairs may indicate Telogen Effluvium.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

Alopecia areata incognita causes sudden hair thinning, responds well to steroids, and is more common in those with genetic hair loss conditions.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

Treatment type and patch size affect hair regrowth patterns in alopecia areata.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Women with thyroid disease are more likely to experience female pattern hair loss, especially if they've had thyroid disease for a long time.

Androgenetic alopecia is common in younger adults, especially with a family history.

There are two main types of alopecia areata with different severity, and diagnosis is made through clinical examination and trichoscopy, influencing treatment choices.

A six-year-old girl unusually had a hair loss condition common in middle-aged women.

Less than a quarter of alopecia areata cases were unusual forms or had paradoxical regrowth.

Ophiasis mainly affects females, lasts longer, and has lower regrowth rates, with a new classification system helping predict treatment response.